Induction With Basiliximab in Renal Transplantation
Author:
Publisher
Elsevier BV
Subject
Transplantation,Surgery
Reference14 articles.
1. Long-term kidney transplant survival;Hariharan;Am J Kidney Dis,2001
2. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era;Meier-Kriesche;Am J Transplant,2004
3. The role of basiliximab in the evolving renal transplantation immunosuppression protocol;Salis;Biologies: Targets and Therapy,2008
4. Redeuction of the occurrence of acute celular rejection among renal transplants treated with basiliximab;Kahan;Transplantation,1999
5. Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin 2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation;Lawen;Transplantation,2003
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Induction Therapy With ATG Compared With Anti-IL2 Basiliximab in Low–Immunologic Risk Kidney Transplant Recipients;Transplantation Proceedings;2019-12
2. Comparison of clinical outcomes of deceased donor kidney transplantations, with a focus on three induction therapies;Korean Journal of Transplantation;2019
3. Oral lichen planus;Clinics in Dermatology;2016-07
4. Basiliximab induction in kidney transplantation with donation after cardiac death donors;Experimental and Therapeutic Medicine;2016-04-08
5. Interleukin-2 Receptor Antagonist Does Not Decrease Biopsy-Proven Acute Rejection among Adult Chinese Kidney Transplant Recipients;Renal Failure;2012-05-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3